BRIEF published on 10/28/2025 at 17:55, 1 month 7 days ago FUTRUE ajuste la rémunération en espèces pour le retrait forcé de PharmaSGP Assemblée Générale Squeeze-out Compensation En Espèces PharmaSGP Futrue GmbH
BRIEF published on 10/28/2025 at 17:55, 1 month 7 days ago FUTRUE Adjusts Cash Compensation for PharmaSGP Squeeze-Out General Meeting Squeeze-out Cash Compensation PharmaSGP Futrue GmbH
PRESS RELEASE published on 10/28/2025 at 17:50, 1 month 7 days ago FUTRUE increases adequate cash compensation under the squeeze-out FUTRUE increases adequate cash compensation under squeeze-out for PharmaSGP Holding SE minority shareholders. Cash compensation raised to EUR 30.64 per share effective immediately Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE FUTRUE
BRIEF published on 09/22/2025 at 15:20, 2 months 12 days ago PharmaSGP Calls Extraordinary General Meeting for Squeeze-out Decision General Meeting Squeeze-out Share Transfer PharmaSGP Futrue GmbH
BRIEF published on 09/22/2025 at 15:20, 2 months 12 days ago PharmaSGP convoque une assemblée générale extraordinaire pour prendre une décision de retrait obligatoire Assemblée Générale Transfert D'actions PharmaSGP Retrait Forcé Futrue GmbH
PRESS RELEASE published on 09/22/2025 at 15:15, 2 months 12 days ago PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out PharmaSGP Holding SE convenes an extraordinary general meeting to resolve on squeeze-out of remaining shareholders. Cash compensation specified at EUR 29.33 per share Extraordinary General Meeting Squeeze-out Cash Compensation PharmaSGP Holding SE Futrue GmbH
BRIEF published on 09/11/2025 at 09:05, 2 months 24 days ago PharmaSGP Releases Preliminary Half-Year Figures for 2025 Adjusted EBITDA Germany PharmaSGP OTC Pharmaceuticals 2025 Revenues
BRIEF published on 09/11/2025 at 09:05, 2 months 24 days ago PharmaSGP publie ses chiffres préliminaires du premier semestre 2025 Allemagne EBITDA Ajusté PharmaSGP Chiffre D'affaires 2025 Médicaments En Vente Libre
PRESS RELEASE published on 09/11/2025 at 09:00, 2 months 24 days ago PharmaSGP publishes preliminary half-year figures for 2025 PharmaSGP Holding SE releases preliminary half-year figures for 2025, showing a 13.0% revenue increase. Adjusted EBITDA declined slightly due to higher expenses. Forecast aims for continued growth amidst global uncertainties Adjusted EBITDA Revenue Increase Growth Forecast PharmaSGP Half-Year Figures
BRIEF published on 08/06/2025 at 16:21, 3 months 29 days ago PharmaSGP annonce sa radiation de la Bourse de Francfort Bourse Bourse De Francfort Radiation PharmaSGP Futrue GmbH
Published on 12/05/2025 at 02:35, 6 hours 43 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 18 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 13 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 18 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 12 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 33 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 33 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 35 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 3 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 18 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
